The gut microbiota is indeed a mainstream field of scientific research worldwide and should not be underestimated
Loading...
When it comes to intestinal flora, some people think it is "magical", think that everything has something to do with it, and even advocate the "omnipotence theory of microflora"; some people jokingly call it "metaphysics", and even have the ridicule of "the mechanism is difficult to find, and the intestinal flora". This is really controversial territory!
In fact, the intestinal microbiota, also known as the "gut microbiome", is the forefront of mainstream scientific research!
We look at PubMed data and show that in the 15 years from 2010 to the present, the number of research publications worldwide has increased dramatically.
The number of research papers on "microbiota" was only 1,178 in 2010 and 27,982 in 2023.
And the number of papers focusing exclusively on "intestinal microbiota" was a pitiful 86 in 2010, and by 2023 this number has soared to 10,360!
In just four months this year, there are 10,924 and 4,152 records of "microbiota" and "gut microbiota" in PubMed in 2024!
According to a statistic we made in 2019, Warm Heart Daily collected and interpreted more than 10,000 documents in the past four years, involving more than 100 countries and regions, more than 5,000 research institutions, more than 9,000 research groups and more than 70,000 researchers. Isn't it a lot more than you think?
Now that we are updating these data, we will introduce it to you at the "529" conference, which is expected to shock you even more!
At that time, in addition to Nature, Science, and Cell (known as CNS), which attracted the most attention in the field of life sciences, JAMA, Lancet, and NEJM (the world's three top medical journals) also continued to publish important research breakthroughs related to intestinal microbiota, and the number of relevant papers included in them was as high as 291, 238, 216, 207, 141, and 99 respectively.
This year, 16 articles from Cell, 13 from Nature and 6 from Science were included in Warm Heart. It is worth mentioning that there are many achievements of Chinese scholars in it, and the local Chinese team alone led 5 of them, which is the best start of the year in history.
Just on May 2, 2024, another Nature article focused on the effects of the gut microbiota of male mice on the health of pregnant mice and offspring!
From these data, it can be seen that the intestinal microbiota is indeed the mainstream scientific research field in the world, which should not be underestimated. I strongly advise you not to ridicule or even negate the efforts of scientists.
Conflict of Interest Statement
Conflict of Interest Statement
He is the co-founder and executive editor of iMeta journal, holds positions in professional institutions such as national societies, and serves as a university chair professor.
However, readers should be reminded that the company he founded and mainly works in, Beijing Warm Heart Biotechnology Research Institute Co., Ltd., is a for-profit commercial organization, and he also serves as chairman and director of this company and a number of affiliated companies.
In addition, he is also a consultant or consultant officially employed by Shanghai Pharmaceutical, H&H Group, Mengniu Group and other enterprises, and provides strategy, product and other consulting services for many other enterprises.
Mr. Warmheart benefits from the above-mentioned for-profit organizations through shareholdings, salaries, dividends and consulting fees, and although he always wants to uphold a scientific, objective and impartial attitude at the time of writing, the following conflicts of interest may inevitably exist due to the above reasons:
- Loss of rigor, objectivity, and professionalism in science communication due to commercial motives.
- Emphasis is placed on the products and services of interested companies and other potential options are neglected.
- Emphasize the strengths of the stakeholder companies and downplay their weaknesses.
In order to avoid and reduce the non-objectivity caused by conflicts of interest, Mr. Warmheart will take the following measures:
- This statement is made public, clearly indicating the relationship between the interested companies.
- Evaluate all organizations, including stakeholder companies, objectively and fairly.
- Readers are encouraged to make criticisms and suggestions and to improve them.
When reading Mr. Warmheart's articles, readers should pay attention to understanding his business background, and maintain rational judgment and critical thinking.